Harter Secrest & Emery Advises Athenex, Inc. in Connection with $110 Million Public Offering

Harter Secrest & Emery LLP (HSE), a full-service business law firm with offices throughout New York, recently represented Athenex, Inc. (Nasdaq: ATNX) in a public offering of 10,000,000 shares of Athenex common stock.  The underwriters were also granted an over-allotment option to purchase 1,500,000 additional shares of Athenex common stock. The HSE Securities and Capital Markets team for the transaction included Alexander R. McClean, Sarah H. Brennan, C. Christopher Murillo, and Ryan A. Whelpley

Founded in 2003 in Buffalo, NY, Athenex is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Their mission is to become a global leader in bringing innovative cancer treatments to the market and improve health outcomes. The company has operations across the U.S., China, Hong Kong, Taiwan, the U.K., and Latin America. Athenex intends to use the net proceeds from the proposed offering to continue to expand and strengthen its commercial infrastructure, execute label expansion strategies for Oral Paclitaxel, advance the development of its product candidates, invest in its chemistry, manufacturing and controls development for its product candidates and manufacturing infrastructure, and fund working capital and other general corporate purposes.

Harter Secrest & Emery is recognized as a leader in the securities and capital markets industry. With 10 attorneys devoted to practicing securities and capital markets law in western New York, the firm brings a depth and breadth of experience unmatched in the region. The firm has represented issuers and underwriters in over 60 public offerings, with clients ranging from businesses seeking start-up capital to Fortune 500 companies. HSE’s securities practitioners assist clients with private and public offerings of securities, ongoing regulatory compliance and reporting, proxy solicitations, tender offers, and securities litigation and arbitration before the Securities and Exchange Commission, NYSE, Nasdaq, FINRA, and state and federal courts.

click here to view Harter Secrest & Emery Advises Athenex, Inc. in Connection with $110 Million Public Offering as a PDF

Attorney Advertising. Prior results do not guarantee a similar outcome. This publication is provided as a service to clients and friends of Harter Secrest & Emery LLP. It is intended for general information purposes only and should not be considered as legal advice. The contents are neither an exhaustive discussion nor do they purport to cover all developments in the area. The reader should consult with legal counsel to determine how applicable laws relate to specific situations. ©2022 Harter Secrest & Emery LLP